TCWM
FSTX

Total Clarity Wealth Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Total Clarity Wealth Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,000
Closed -$13K – 1042
2022
Q2 		$13K Buy
+2,000
New +$6.74K 0.01% 617
2022
Q1 		– Sell
-3,500
Closed -$18K – 986
2021
Q4 		$18K Buy
3,500
+3,000
+600% +$18.1K 0.01% 588
2021
Q3 		$4K Buy
+500
New +$3.43K ﹤0.01% 876

Other funds holding FSTX

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Total Clarity Wealth Management's FSTX Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2022, closing a stake of 2,000 shares — an estimated $13K sold.

Total Clarity Wealth Management first reported a position in FSTX in Q3 2021 and held it in 3 quarters. The position peaked at $18K in Q4 2021. 54 funds tracked by Wall St. Rank hold FSTX as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 2,000 F-star Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $13K.
  • Total Clarity Wealth Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Total Clarity Wealth Management's F-star Therapeutics, Inc. Common Stock position peaked at $18K in Q4 2021.
  • 54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.